hotspot -WSS

hotspot

author：fashion 2025-09-29 23:12:42 - browse：988

In a lab at Harvard Medical School, Professor David A. Sinclair looks into the camera from behind a row of bottles — coverage from STAT — David Sinclair in his lab at Harvard Medical School. Craig F. Walker/Globe Staff

Renowned Harvard University geneticist and longevity researcher David Sinclair recently made an astonishing assertion: Scientists had developed the first pill — well, a soft, beef-flavored chew — “proven to reverse aging” in dogs. Which miracle molecules delivered this supposed scientific breakthrough, he didn’t say. But he told his 438,000 followers on X where they could buy it: the website of Animal Bioscience, a veterinary supplement company he founded and which is headed by his brother, Nick Sinclair.

The claim in a company news release, followed by the tweet stating that the supplement was “proven to slow the effects of aging,” has sparked outrage from other scientists online, and the board of an international organization of top longevity researchers — which David Sinclair leads — will discuss the matter at its meeting this week.

Despite his enthusiasm, there is no published scientific research that has yet demonstrated the compounds in Animal Bioscience’s supplements — which have been on the market for more than a year — reverse or even slow aging in dogs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： Health insurers say they are turning to AI to cut costs, improve care

WSS

Methadone treatment changes are coming. Do they go far enough?

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Dark money group runs ads on China biotech bill

Dark money group runs ads on China biotech bill

Gene editing the human germline: What are the risks?

Addiction doctors spar with methadone clinics over legislation

hotspot

hotspot

leisure time

In Memoriam: Notable people who died in 2023

Argenx readies a blockbuster opportunity with drug for autoimmune disease

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Virtual Event: March of the Biosimilars

Wildfire smoke exposes gaps in outdoor worker protections

Startling documents reveal new facets of Sacklers' opioid empire

Novavax promises a turnaround & Lilly roils the obesity market

Virtual Event: March of the Biosimilars

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Neuroscience’s long legacy of racism

Wikipedia

AI used to predict Covid

David Sabatini, ex

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Methadone treatment changes are coming. Do they go far enough?

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Virtual Event: March of the Biosimilars

Wikipedia

focus

knowledge

knowledge